The epidemiology of invasive fungal infections is changing, with new populations at risk and the emergence of resistance caused by the selective pressure from increased usage of …
Abstract Objectives Coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) has emerged as a complication in critically ill COVID-19 patients. The …
S Shen, Y Chen, J Zhou, H Zhang, X Xia… - Advanced Energy …, 2023 - Wiley Online Library
Biosynthesis methods are considered to be a promising technology for engineering new carbon‐based materials or redesigning the existing ones for specific purposes with the aid …
M Seif, TK Kakoschke, F Ebel, MM Bellet… - Science Translational …, 2022 - science.org
Aspergillus fumigatus is a ubiquitous mold that can cause severe infections in immunocompromised patients, typically manifesting as invasive pulmonary aspergillosis …
S Hatzl, AC Reisinger, F Posch, J Prattes, M Stradner… - Critical Care, 2021 - Springer
Abstract Background Coronavirus disease 19 (COVID-19)-associated pulmonary aspergillosis (CAPA) emerged as important fungal complications in patients with COVID-19 …
Access to the appropriate tools is crucial for early diagnosis and clinical management of invasive fungal infections. This Review aims to describe the invasive fungal infection …
D Seidel, S Wurster, JD Jenks, H Sati… - The Lancet …, 2024 - thelancet.com
The effects of climate change and natural disasters on fungal pathogens and the risks for fungal diseases remain incompletely understood. In this literature review, we examined how …
C Lass-Flörl, S Steixner - Molecular Aspects of Medicine, 2023 - Elsevier
Invasive fungal diseases are common complications in critically ill patients and in those with significant underlying imbalanced immune systems. Fungal co-, and/or super-infections are …
First reports of cases and case series of COVID-19-associated pulmonary aspergillosis (CAPA) emerged during the first months of the pandemic. Prevalence rates varied widely …